© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
RadNet, Inc. (RDNT) stock surged +4.81%, trading at $74.28 on NASDAQ, up from the previous close of $70.87. The stock opened at $70.45, fluctuating between $70.45 and $75.10 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | 70.45 | 75.10 | 70.45 | 74.28 | 801.83K |
| Sep 09, 2026 | 71.31 | 72.56 | 70.08 | 70.87 | 574.81K |
| Sep 08, 2026 | 72.72 | 73.53 | 71.82 | 71.97 | 448.47K |
| Sep 04, 2026 | 73.82 | 74.70 | 73.36 | 73.71 | 501.98K |
| Sep 03, 2026 | 76.22 | 76.27 | 73.27 | 74.62 | 1.14M |
| Sep 02, 2026 | 75.41 | 76.97 | 75.31 | 75.70 | 712.79K |
| Sep 01, 2026 | 75.80 | 76.63 | 74.81 | 75.52 | 762.97K |
| Aug 31, 2026 | 75.25 | 76.30 | 73.50 | 75.82 | 658.09K |
| Aug 28, 2026 | 75.72 | 75.86 | 74.11 | 74.61 | 472.84K |
| Aug 27, 2026 | 75.75 | 76.50 | 74.94 | 75.36 | 528.46K |
| Aug 26, 2026 | 76.96 | 77.79 | 75.29 | 76.47 | 391.29K |
| Aug 25, 2026 | 75.52 | 77.09 | 73.81 | 76.86 | 444.92K |
| Aug 24, 2026 | 76.98 | 77.50 | 74.01 | 74.69 | 549.18K |
| Aug 21, 2026 | 76.96 | 78.29 | 75.86 | 76.82 | 644.94K |
| Aug 20, 2026 | 74.64 | 78.02 | 74.64 | 77.05 | 479.68K |
| Aug 19, 2026 | 75.07 | 76.56 | 74.61 | 75.54 | 371.91K |
| Aug 18, 2026 | 75.79 | 76.45 | 73.73 | 73.83 | 548.62K |
| Aug 17, 2026 | 76.17 | 76.66 | 75.00 | 75.93 | 596.2K |
| Aug 14, 2026 | 76.87 | 78.14 | 75.84 | 76.35 | 632.34K |
| Aug 13, 2026 | 77.00 | 78.16 | 76.44 | 77.31 | 663.37K |
RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.
| Employees | 9060 |
| Beta | 1.38 |
| Sales or Revenue | $1.62B |
| 5Y Sales Change% | 0.255% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Diagnostics & Research |